Addressing recent docking challenges: a hybrid strategy to integrate template-based and free protein-protein docking
Additionally, semaglutide should not be used by: Pregnant people People of any sex planning to conceive in the near future Anyone with a personal or family history of certain thyroid cancers, including medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia syndrome type 2 (MEN 2) Phentermine should not be used by people who are pregnant or nursing, who have recently started taking monoamine oxidase inhibitors, or who have: A history of heart problems Hyperthyroidism Glaucoma Agitation A history of substance use disorder Who should not combine semaglutide and phentermine
Semaglutide targets the GLP-1 pathway, while tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone effect that may influence blood sugar, satiety, and fat metabolism more comprehensively
They influence tolerability, energy, blood sugar stability, and whether weight loss comes from fat or muscle